GeVIR Banner

Export Results to CSV Clear Search

Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
MYBL1 ENST00000522677 16.29 0.65 5.71 1.48 4.12 3.33 0.80 0.28 0.28
TAF4 ENST00000252996 3.89 0.66 0.76 3.77 4.12 4.57 0.30 0.28 0.20
MACF1 ENST00000545844 14.10 0.66 4.74 1.63 4.11 3.68 0.71 0.28 0.25
FLNA ENST00000369850 25.53 0.67 10.70 1.35 4.11 2.19 1.19 0.28 0.43
CHD8 ENST00000399982 3.74 0.67 0.70 3.78 4.11 4.60 0.30 0.28 0.20
SNRNP200 ENST00000323853 4.59 0.68 0.93 3.67 4.10 4.46 0.30 0.28 0.21
STXBP1 ENST00000373302 2.39 0.68 0.39 4.11 4.10 4.77 0.27 0.28 0.18
C17orf104 ENST00000409122 29.22 0.69 12.50 1.10 4.10 2.21 1.56 0.28 0.50
WDR26 ENST00000414423 2.34 0.69 0.38 4.10 4.09 4.77 0.27 0.28 0.18
FAM120C ENST00000375180 12.25 0.70 3.83 1.68 4.09 3.77 0.59 0.28 0.24
DCAF5 ENST00000341516 5.29 0.70 1.16 3.40 4.08 4.44 0.32 0.28 0.20
GTPBP4 ENST00000360803 49.37 0.71 23.12 0.57 4.08 1.20 1.81 0.28 1.00
CUL4B ENST00000404115 6.02 0.71 1.40 3.05 4.08 4.35 0.34 0.28 0.23
TRIM33 ENST00000358465 4.43 0.72 0.91 3.71 4.10 4.48 0.29 0.28 0.21
SRCAP ENST00000262518 20.17 0.72 7.80 1.53 4.09 2.63 1.00 0.28 0.34
COPA ENST00000368069 9.50 0.73 2.61 2.16 4.09 4.01 0.46 0.28 0.23
MYT1L ENST00000428368 4.99 0.73 1.07 3.56 4.11 4.42 0.30 0.28 0.21
UBP1 ENST00000283629 9.03 0.74 2.49 2.33 4.10 4.02 0.46 0.27 0.24
MYH9 ENST00000216181 8.39 0.74 2.25 2.53 4.12 4.07 0.44 0.27 0.23
FRMPD4 ENST00000380682 23.90 0.75 9.86 1.37 4.12 2.30 1.11 0.27 0.41
EP300 ENST00000263253 8.76 0.75 2.42 2.42 4.11 4.02 0.44 0.27 0.23
WAC ENST00000354911 19.00 0.76 7.24 1.58 4.11 2.81 0.95 0.27 0.33
TET3 ENST00000409262 16.75 0.76 6.02 1.46 4.13 3.28 0.83 0.27 0.30
MN1 ENST00000302326 40.52 0.77 18.65 0.86 4.12 1.58 1.75 0.27 0.81
TOPBP1 ENST00000260810 35.95 0.77 16.18 0.94 4.12 1.71 1.87 0.27 0.66

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.